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Delirium detection in older acute medical
inpatients: a multicentre prospective
comparative diagnostic test accuracy
study of the 4AT and the confusion
assessment method
Susan D. Shenkin1, Christopher Fox2, Mary Godfrey3, Najma Siddiqi4, Steve Goodacre5, John Young6, Atul Anand7,
Alasdair Gray8, Janet Hanley9, Allan MacRaild8, Jill Steven8, Polly L. Black8, Zoë Tieges1, Julia Boyd10,
Jacqueline Stephen10, Christopher J. Weir10 and Alasdair M. J. MacLullich1*
Abstract
Background: Delirium affects > 15% of hospitalised patients but is grossly underdetected, contributing to poor care. The
4 ‘A’s Test (4AT, www.the4AT.com) is a short delirium assessment tool designed for routine use without special training.
The primary objective was to assess the accuracy of the 4AT for delirium detection. The secondary objective was to
compare the 4AT with another commonly used delirium assessment tool, the Confusion Assessment Method (CAM).
Methods: This was a prospective diagnostic test accuracy study set in emergency departments or acute medical wards
involving acute medical patients aged ≥ 70. All those without acutely life-threatening illness or coma were eligible.
Patients underwent (1) reference standard delirium assessment based on DSM-IV criteria and (2) were randomised to
either the index test (4AT, scores 0–12; prespecified score of > 3 considered positive) or the comparator (CAM; scored
positive or negative), in a random order, using computer-generated pseudo-random numbers, stratified by study site,
with block allocation. Reference standard and 4AT or CAM assessments were performed by pairs of independent raters
blinded to the results of the other assessment.
Results: Eight hundred forty-three individuals were randomised: 21 withdrew, 3 lost contact, 32 indeterminate diagnosis,
2 missing outcome, and 785 were included in the analysis. Mean age was 81.4 (SD 6.4) years. 12.1% (95/785) had delirium
by reference standard assessment, 14.3% (56/392) by 4AT, and 4.7% (18/384) by CAM. The 4AT had an area under the
receiver operating characteristic curve of 0.90 (95% CI 0.84–0.96). The 4AT had a sensitivity of 76% (95% CI 61–87%) and a
specificity of 94% (95% CI 92–97%). The CAM had a sensitivity of 40% (95% CI 26–57%) and a specificity of 100%
(95% CI 98–100%).
Conclusions: The 4AT is a short, pragmatic tool which can help improving detection rates of delirium in routine
clinical care.
Trial registration: International standard randomised controlled trial number (ISRCTN) 53388093. Date applied
30/05/2014; date assigned 02/06/2014.
Keywords: Delirium, Diagnostic test accuracy, 4AT, Confusion assessment method (CAM), Sensitivity, Specificity,
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Background
Delirium is a severe neuropsychiatric syndrome, usually
triggered by underlying medical illness, surgery, or drugs,
which affects at least 15% of hospital inpatients [1–4]. It is
more common in older people [5] and people with de-
mentia [6]. Delirium comprises acute onset of dis-
turbances in arousal, attention, and other domains of
cognition, hallucinations, and delusions [7, 8]. Delirium is
important because as well as being highly prevalent in
hospitalised patients, it strongly predicts poor outcomes
such as falls, other medical complications, new institutio-
nalisation, and mortality [1, 6, 9–13]. It is also associated
with patient and carer distress [14–16]. At least two thirds
of cases are not identified in the emergency department
and general medical settings [17–21]. The reasons for this
include time constraints and lack of education and train-
ing [22–24]. Because formal psychiatric assessment for
delirium diagnosis takes considerable time, guidelines and
pathways advocate the use of brief assessment tools for
delirium detection. Two assessment tools extensively used
in clinical practice are the 4 ‘A’s Test (4AT) and the short
form of the Confusion Assessment Method (CAM).
The 4AT [25, 26] comprises four items: (A) Alertness,
(B) Abbreviated Mental Test-4, (C) Attention (Months
Backwards test), and (D) acute change or fluctuating
course [25, 27], Fig. 1. The 4AT was not derived directly
from a single set of diagnostic criteria; rather, it has items
that inform the core features of standard diagnostic
criteria. It has a score range of 0–12, with scores of 4 or
more (> 3) suggesting possible delirium. The structure of
the 4AT is designed such that there are different ways of
reaching an overall positive score (> 3). Items (A) and (D)
each gives a score of 0 if negative and 4 if positive. The
rationale for items (A) and (D) individually potentially
triggering an overall positive 4AT score is that altered
arousal and acute change are both highly specific features
of delirium [28–30]. The AMT-4 (B) gives a score of 1 for
one mistake and 2 for two or more mistakes or if the
patient is untestable. The attention test (C) gives a score
of 1 if unable to complete 7months backwards and 2 if
untestable. Therefore, patients who perform poorly or are
untestable on both cognitive tests (B+C), score 4 from
items (B) + (C), triggering further assessment for delirium.
The rationale for the (B) and (C) scoring is that many
patients with delirium are unable to undergo cognitive
testing because of reduced arousal or other reasons
[31, 32], and they would be unscorable or scored as
negative on assessments that require cognitive testing, but
the 4AT identifies that further assessment is required. The
4AT takes around 2min and does not require special
training. It is recommended in several pathways and
guidelines and is in wide routine clinical use in the UK
and internationally. Since publication on a dedicated web-
site [26] in 2011, the 4AT has to date been evaluated in
eight validation studies [25, 33–39] involving a total of
2577 patients, 479 with delirium. These studies have
used varying designs, reference standards, clinical popu-
lations, and inclusion criteria. Sensitivities are reported as
83–100% and specificities ranging from 70 to 99%.
The CAM (short form) [28] comprises brief cognitive
testing and interview followed by a four-item algorithm in
which four DSM-III-R criteria for delirium are rated as be-
ing present or absent: (A) acute onset and fluctuating
course, (B) inattention, (C) disorganised thinking, and (D)
level of consciousness. To score positive on the CAM, both
(A) and (B) must be positive, plus either or both of (C) and
(D). The CAM requires specific training in rating each of
the features. The cognitive testing which is carried out
before completing the algorithm is not specified in the
manual [40]. With the pre-algorithm interview and cogni-
tive testing, it takes 5–10min to complete [40]. The CAM
is included in multiple international guidelines and path-
ways, including the UK NICE Guidelines on Delirium
published in 2010 [41]. According to published systematic
reviews [42–46] and a literature review carried out on 19
February 2019, the CAM has been evaluated in 22 valid-
ation studies since publication in 1990 [31, 47–66], with a
total of 2437 participants (620 with delirium). As with the
4AT validation studies, these studies vary in design, popula-
tion, etc. The reported range of sensitivities for delirium de-
tection is 13–100% and the range of specificities 84–100%.
The primary objective of the present study was to
conduct an evaluation of the diagnostic accuracy of the
4AT for delirium against a reference standard based on
DSM-IV in patients aged 70 years and over recently admit-
ted to hospital recruited prospectively. The secondary
objective was to compare the diagnostic test accuracy of
the 4AT and CAM. The rationale for performing the
comparison is that the 4AT and CAM are both widely used
and recommended, yet the 4AT and CAM differ in their
scoring systems, and the 4AT offers potential advantages
that include a shorter testing duration and no need for
specific training and a process for handling untestable
patients. Given these differences, it is of interest to
practitioners and researchers to know if the perfor-
mance of the 4AT is at least equivalent to the CAM.
Additionally, both the 4AT and the CAM have been
evaluated in multiple validation studies, but there are
no published studies comparing the performance of
these tools under the same study conditions.
Methods
We followed the Standards for Reporting Diagnostic
Accuracy (STARD) 2015 guidelines [67] for reporting
diagnostic accuracy studies. The study was registered:
International Standard Randomised Controlled Trial
Number (ISRCTN) 53388093, UK Clinical Research
Network ID: 19502, and the protocol published before
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database lock and statistical analysis. The objectives de-
scribed in the protocol not reported here (e.g. 12-week
outcomes) will be disseminated separately.
Study design: overview
The study protocol has been published. In summary,
patients aged 70 or over in emergency departments
or acute general medical wards were prospectively re-
cruited in three UK sites (Edinburgh, Bradford, and
Sheffield). Each patient underwent (a) a reference
standard delirium assessment lasting up to 20 min
and (b) either the 4AT or the CAM. Participants were
randomised to the 4AT or the CAM and also to the
ordering of the reference standard and the 4AT or
Fig. 1 The 4 ‘A’s Test (4AT)
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CAM assessment. The study flowchart is shown in
Fig. 2.
Participants
Potentially eligible participants were those without an
acutely life-threatening illness or coma, in the emergency
department or acute general medical wards. Initially, the
recruitment windows were 4 h for the emergency depart-
ment and 24 h for the acute general medical wards. Four
months after the study commencement (from 19 February
2016), these were extended to 12 h and 96 h, respectively,
to facilitate recruitment, particularly with respect to seek-
ing proxy consent. The potential impact of this was
explored in planned subgroup analyses.
Patients were recruited by researchers between 0800
and 2200, Monday to Friday, from eligible patients identi-
fied by the clinical team. Patients were initially approached
alphabetically, then in approximately the last third of the
recruitment period, through liaison with clinical staff,
prioritising those at higher risk of delirium on clinical
grounds (e.g. older age, likely to be admitted, higher
degree of ongoing acute and chronic illnesses) to obtain a
Capacity assessment 
Researcher A*: 
reference standard 
Researcher B: 4AT 
OR CAM 
Researcher A*: 
reference standard
Researcher B: 4AT 
OR CAM 
Clinical staff informed of outcome of reference standard assessment 
*Researcher A (i.e. the 
individual doing the consenting) 
will also always perform the 
reference standard assessment. 
Researcher A status is not linked 
to a particular individual 
Consent sought 
Consent 
denied 
Exclude
Consent 
granted 
Randomisation of order of: (4AT or CAM) and 
reference standard
Incapable of giving 
informed consent
Proxy consent is 
sought via consultee or 
nominee 
Unavailable 
Excluded 
A member of the clinical team (which could include the 4AT study researcher depending 
on local arrangements) approaches the patient to ask if they would mind speaking to a 
researcher about this study. 
Patient says yes Patient is drowsy or is 
obviously incapable of 
discussing study 
Patient says no 
Excluded 
Lists of consecutive admissions to ED, medical admission units or MOE units, aged 70 
or over, already had medical assessment
Research Nurse A goes to the doctor who has just seen the patient, or a nurse who is 
familiar with the patient. Asks if patient fulfils basic inclusion & exclusion criteria.
Excluded through ineligibility. 
Reason and age of patient recorded. 
Fig. 2 Diagnostic accuracy study: overview flowchart. ED, Emergency Department; MOE, Medicine of the Elderly; 4AT, 4 ‘A’s Test; CAM, Confusion
Assessment Method
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more representative sample of participants because in-
terim analysis found a lower than expected rate of
recruitment of patients who lacked capacity and thus
required proxy consent. These changes to the recruitment
processes were approved by the Trial Steering Committee.
Informed consent was sought by trained researchers.
Where the potential participant lacked the capacity to
consent, recruitment proceeded under the provisions of
the Mental Capacity Act, 2005, in England or Adults with
Incapacity (Scotland) Act, 2000, using an appropriate
personal or nominated consultee, guardian, welfare
attorney, or nearest relative.
Test methods
Researchers were nurses or trained graduate clinical
research associates who underwent a systematic and
detailed training process involving teaching on delirium
and dementia assessment. Additionally, training on the
CAM was provided according to the guidance given in
the CAM instruction manual [40]. Specific training on
the 4AT was not provided as the tool was designed such
that this is not required. The study team had regular
teleconferences to discuss the conduct of the study.
The reference standard assessment was based on
DSM-IV. These diagnostic criteria were used rather than
DSM-5 because the study, ethics applications, and training
procedures were initiated at a similar time to publication
of DSM-5, and it was not yet in use by the study team;
because DSM-IV had been used in large numbers of
delirium studies thus providing more direct comparability
with the existing literature; and because of the concern
that there was insufficient time to develop and test valid
methods for reference standard assessment using DSM-5.
The reference standard drew from several sources of
information including all items from the Delirium Rating
Scale-Revised-98 (DRS-R98) [68] and using the instruc-
tions from the manual, which include raters seeking
informant history and inspection of clinical records, and a
set of neuropsychological tests designed to detect core
features of delirium [69, 70] comprising Observational
Scale for Level of Arousal [29, 71], the Richmond
Agitation-Sedation Scale [72], Digit Span [73], the
Vigilance A test [74], the DelApp objective test of atten-
tion [75–77], and standard object naming and orientation
questions. These assessments were used together to
inform a binary diagnosis of delirium based on DSM-IV
criteria. The initial diagnosis was recorded by the re-
searcher performing the assessment for the purposes of
providing immediate information to the clinical team.
These initial results of the reference standard assessment
were provided by this researcher to the clinical teams after
the study 4AT or CAM were completed, through both an
entry in the clinical notes and a verbal discussion. The
final and definitive ascertainment for the study was
performed later, via expert consensus from a panel com-
prising ZT (a psychologist), SDS (a geriatrician), and
AMJM (a geriatrician), each with many years of expe-
rience of delirium assessment (> 1000 episodes indivi-
dually). This final ascertainment was based on the
information generated by the reference standard assess-
ment in relation to the DSM-IV criteria, blinded to the
knowledge of whether the participant had undergone the
4AT or CAM, or the results of these tests. Where there
was disagreement, the panel discussed each case using the
available information and reached consensus. Where the
reference standard assessment results did not provide
enough information to provide a definite diagnosis of de-
lirium, the ascertainment was judged to be indeterminate.
The 4AT was scored according to the guidance notes on
the 4AT form [26], using a combination of sources of
available information including case notes, informants,
and bedside assessment. As per the initial design of the
4AT, scores of > 3 were used to indicate possible delirium.
If patients were unable to undergo cognitive testing
because of reduced arousal, the cognitive items 2 and 3
were scored as ‘untestable’ and each given a score of 2 as
per the 4AT guidance notes.
The CAM algorithm was scored following an interview
and a set of cognitive tests, and other sources of available
information including case notes and informants, as
recommended in the CAM instruction manual [40]. The
interview comprised general questions about the patient’s
hospital stay followed by a set of cognitive tests compris-
ing the following: days of the week backwards, counting
from 20 down to 1, orientation (current day, identifying if
it is day or night, current year, last meal, how long in hos-
pital, city, name of the hospital, floor of the hospital),
memory (3-word recall immediately, up to 3 trials until all
3 words recalled or 3 trials repeated; then recall at 5min),
and clock drawing. The CAM algorithm was scored as per
the instruction manual. Where an item could not be
assessed, for example, if the patient was unable to speak
or write and thus could not undergo assessment for dis-
organised thinking (see instruction manual), the item was
scored as negative.
The presence of dementia was sought through either a
formal diagnosis of dementia in the clinical records and/
or, when possible, the Informant Questionnaire on Cogni-
tive Decline in the Elderly (IQCODE) using a cut-off score
of ≥ 3.44 [78].
Ordering of reference standard delirium assessment, 4AT
and CAM
After the consent process was complete, participants were
randomised in a 1:1 ratio to (a) reference standard first
then either 4AT or CAM or (b) either 4AT or CAM first
then reference standard via a secure online system using
computer-generated pseudo-random numbers, stratified
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by study site, with block allocation. The reference standard
assessment was performed by the researcher who con-
ducted the capacity assessment and consenting process. A
different researcher from the one performing the reference
standard assessment performed either the 4AT or the
CAM. Researchers performed the 4AT or the CAM
according to the randomisation, with no individual re-
searcher responsible for performing either the 4AT or the
CAM; that is, each researcher performed approximately
equal numbers of the 4AT and the CAM. The two assess-
ments took place strictly within a maximum of 2 h of each
other, with a target interval of 15min. Researchers were
blinded to each other’s assessments, that is, reference
standard results were not available to those performing the
index and comparator tests, and vice versa. The design of
either 4AT or CAM rather than both 4AT and CAM being
performed by each participant was chosen to avoid burden
on participants, and also because the CAM testing process
is longer than the 4AT and information from the CAM
process could influence scoring of the 4AT, some influence
of 4AT item scores on the CAM could also be possible.
Statistical analysis
All analyses were performed using SAS version 9.3 (SAS
Institute Inc., Cary, NC, USA).
Primary objective
We calculated positive and negative predictive values,
sensitivity, and specificity for 4AT versus the reference
standard. We reported the area under the receiver opera-
ting characteristic (ROC) curve and its 95% confidence
interval (CI) for the 4AT.
Secondary objective
Comparison of 4AT and CAM: we calculated positive
predictive values (PPV), negative predictive values (NPV),
sensitivity, and specificity (with exact binomial 95% CI) for
CAM and 4AT, and estimated the difference (4AT minus
CAM) for each, assessing statistical significance of differ-
ences using Fisher’s exact test. The area under the ROC
curve could not be calculated for the CAM as the out-
come is binary. The overall performance of 4AT and
CAM were each summarised using Youden’s Index
(sensitivity minus false-positive rate) and the diagnos-
tic odds ratio of sensitivity to specificity.
Subgroup analyses
Predefined subgroup analyses assessed the impact of (a)
time from presentation to recruitment (analysing those
tested before or after 4 h (ED) or 24 h (medical ad-
missions)) for 4AT and (b) time between index test and
reference standard (analysing those tested within 30min
compared to those tested later) for both 4AT and CAM.
Sensitivity analyses
We performed predefined sensitivity analyses where the
reference standard was indeterminate by defining delirium
as present and then absent. We also performed a post hoc
sensitivity analysis by using the initial delirium classifica-
tion recorded by the researcher at the time of the original
bedside assessment (which was performed to inform
clinical staff at that time). A further post hoc sensitivity
analysis assumed that any patient with a missing result for
the index test (4AT or CAM) had delirium.
Missing data
If data were missing for the reference standard assess-
ment, CAM or 4AT, or if the reference standard assess-
ment did not yield a clear diagnosis, data from these
individuals were removed from statistical analysis.
Sample size
We planned to randomise 900 patients, 450 to assessment
by 4AT and 450 to CAM. For each of 4AT and CAM, the
width of the two-sided 95% confidence interval for speci-
ficity would be up to ± 0.050, and for sensitivity, up to ±
0.120. The secondary objective comparing 4AT and CAM
would have 83% power to detect a difference in specificity
of 0.10 and 80% power to detect a difference in sensitivity
of 0.22, for a 5% two-sided significance level and analysis
by continuity corrected chi-squared test.
Results
Study recruitment commenced on 19 October 2015 and
was completed on 30 December 2016, with final follow-
up data collection and locking of the database on 29
June 2017. Four thousand nine hundred twenty-eight
patients were eligible, from whom 843 individuals (17.1%)
were recruited across the three sites and 2 withdrew
before data collection, leaving 841 with data for analysis of
whom 19 withdrew, 3 lost contact, 32 were classified as
indeterminate from the reference standard data, and 2 had
a missing outcome. Therefore, 785 individuals were
included in the analyses (Fig. 3). Recruitment did not
reach the target of 900 through a combination of a
lower than expected rate of recruitment and a limit
to the available recruitment period. However, the
number recruited allowed for adequate power to test the
main hypotheses as confirmed by the study statisticians
and the Trial Steering Committee.
Reference standard delirium prevalence was 12.1%
(n = 95 of 785). Individuals with delirium were older
and were more likely to have dementia as documented
through the clinical records or through the informant
questionnaire (Table 1). Baseline characteristics for
those randomised to the 4AT or CAM are shown in
Additional file 1: Table S1. Reference standard delirium
prevalence in those who had a valid 4AT assessment
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was 12.5% (n = 49 of 392), and in those who had a valid
CAM assessment was 10.9% (n = 42 of 384). Delirium
prevalence using the 4AT only as a diagnostic test was
14.3% (n = 56 of 392) and for CAM only as a diagnostic
test was 4.7% (n = 18 of 384).
Diagnostic test accuracy of 4AT and CAM
The main diagnostic test accuracy results for the 4AT
and CAM are shown in Table 2. At a 4AT cut-off score
for delirium of > 3, the sensitivity was 76% (95% CI 61 to
87%) and the specificity was 94% (95% CI 92 to 97%).
The performance at different cut-off scores is shown in
Additional file 2: Table S2. The area under the ROC curve
for the 4AT was 0.90 (95% CI 0.84 to 0.96) (Fig. 4). The
CAM had a sensitivity of 40% (95% CI 26 to 57%) and a
specificity of 100% (95% CI 98 to 100%).
Subgroup analyses
There was no statistically significant difference in the diag-
nostic test accuracy of the 4AT between those recruited
early and those recruited later after the initial presentation
(Fisher’s exact test p values: sensitivity p = 0.19, specificity
p = 0.75, PPV p = 0.47, NPV p = 0.24).
There was no statistically significant difference in the
performance of either test regardless of whether or not
it was performed within 30 min of the reference stand-
ard (Fisher’s exact test p values: sensitivity p = 0.16,
specificity p = 0.24, PPV p = 1.00, NPV p = 0.56).
Fig. 3 STARD diagram of the flow of participants through the study (total across all three sites)
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Sensitivity analyses
Indeterminate reference standard
Assuming delirium was present for all indeterminate re-
ference standards (N = 32) reduced the sensitivity of both
the 4AT and CAM: 64% (95% CI 52 to 76%) and 33% (95%
CI 21 to 47%), respectively (Additional file 3: Table S3).
Assuming delirium was absent for all indeterminate re-
ference standards did not substantially alter the diagnostic
accuracy of the 4AT or CAM (Additional file 4: Table S4).
Delirium reference standard
Using the researchers’ initial reference standard assess-
ment of delirium, the sensitivity of the 4AT was 83%
(95% CI 70 to 93%) and the specificity was 94% (95% CI
91 to 96%). The sensitivity (40%; 95% CI 25 to 56%) and
specificity (99%; 95% CI 98 to100%) of the CAM did not
change substantially.
Missing index test
If delirium was scored as present where the index
test result was missing, this did not substantially alter
the diagnostic test accuracy of the 4AT or CAM
(Additional file 5: Table S5).
Discussion
This study found that the 4AT had a sensitivity of 76%
and a specificity of 94% for delirium as assessed indepen-
dently by a reference standard. The area under the ROC
curve was high at 0.90. These findings, in a relatively large,
STARD-compliant study, provide support additional to
the existing literature for the use of the 4AT as a delirium
assessment instrument in clinical practice which has
acceptable overall diagnostic test accuracy. The study also
found that the CAM showed lower sensitivity than the
4AT, at 40%, with higher specificity, at 100%. This is the
first randomised comparison of two of the most widely
used delirium assessment tools in clinical practice and
thus is informative for researchers with respect to their
respective performance under the same study conditions.
The diagnostic test accuracy of the 4AT was broadly
similar to the existing studies [25, 33–39], albeit with
lower sensitivity and higher specificity than most prior
Table 1 Baseline demographic and clinical characteristics stratified by reference standard delirium status
Total (N = 785) Delirium present (N = 95) Delirium absent (N = 690) p value
Age (years)
Mean (SD) 81.4 (6.4) 83.5 (6.9) 81.1 (6.3) 0.0007
Median [Q1–Q3] 81.0 [77.0–86.0] 84.0 [78.0–89.0] 81.0 [77.0–86.0]
Gender
Male, n (%) 349 (44.5%) 34 (35.8%) 315 (45.7%) 0.0697
Female, n (%) 436 (55.5%) 61 (64.2%) 375 (54.3%)
Dementia diagnosis and/or IQCODE ≥ 3.44
Yes, n (%) 111 (14.2%) 43 (45.3%) 68 (9.9%) < 0.0001
No, n (%) 673 (85.5%) 52 (54.7%) 621 (90.1%)
Missing*, n (%) 1 (0.1%) 0 (0.0%) 1 (0.1%)
Location of first assessment
Emergency department, n (%) 53 (6.8%) 10 (10.5%) 43 (6.2%) 0.2624
Acute general medical ward, n (%) 665 (84.7%) 76 (80.0%) 589 (85.4%)
Hospital ward, n (%) 67 (8.5%) 9 (9.5%) 58 (8.4%)
p value from chi-squared (categorical variables) or t test (continuous)
IQCODE Informant Questionnaire for Cognitive Impairment in the Elderly
*Missing category not included in chi-squared test
Table 2 Diagnostic test accuracy of the 4AT the CAM for diagnosis of delirium (defined by reference standard assessment)
Sensitivity Specificity Positive predictive value Negative predictive value Youden’s Index
4AT (> 3), n (95% CI) 76% (61 to 87%) 94% (92 to 97%) 66% (52 to 78%) 96% (94 to 98%) 0.70
CAM Positive, n (95% CI) 40% (26 to 57%) 100% (98 to 100%) 94% (73 to 100%) 93% (90 to 96%) 0.40
Difference in Proportions 36% (15 to 53%) − 6% (− 14 to 2%) − 28% (− 53 to − 2%) 3% (− 4 to 11%)
p value 0.0012 < 0.0001 0.0297 0.0629
Numbers are estimates (95% CI). Youden’s Index is equal to sensitivity + specificity − 1, a value of zero indicates no value, and a value of 1 indicates a perfect test.
The difference in proportions is 4AT-CAM for each of the tabulated measures of diagnostic accuracy, accompanied by the corresponding p value from Fisher’s
exact test comparing proportions
CI confidence interval, PPV positive predictive value, NPV negative predictive value
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studies. The difference in the sensitivity results may reflect
differences in the study population, the reference standard
assessment, and recruitment processes. One prior study
found higher sensitivity (87%) and lower specificity (70%)
and a similar area under the ROC curve of 0.84 in an un-
selected consecutive clinical sample using a design that
did not require consenting (N = 434) [35]. The 4AT in-
volves a degree of subjectivity with respect to the assess-
ment of the level of alertness; raters are asked to rate this
in a binary fashion, that is, as abnormal or normal. The
reference standard assessment involves a more detailed
approach to the assessment of arousal involving the
three different tools: the Observational Scale of Level of
Arousal, the Richmond Agitation-Sedation Scale, and
the arousal element of the DelApp smartphone test of
attention and arousal. It is possible that the simpler
binary assessment tended to a lower level of positive
score than the more complex and nuanced reference
standard assessment process. Additionally, the bedside
element of the 4AT (items 1–3) usually takes less than
1 min, as compared to around 20 min for the reference
standard assessment. This gives more opportunity in
the reference standard assessment for the observation
of reduced arousal as well as fluctuation of symptoms.
Further planned analyses of the present dataset will
explore the relationships of individual test components
of the 4AT (and the CAM) to the overall test score and
components of the reference standard.
In this study, the CAM showed very high specificity and
modest sensitivity for delirium. The high specificity is
aligned with prior studies, the vast majority of which have
found specificities of over 90%. The sensitivity of 40% was
lower than in the majority of published studies. However,
unlike with specificity, the literature shows notable hetero-
geneity in the findings with respect to CAM sensitivity,
with several studies also showing lower sensitivities for the
CAM [47, 49, 50, 56, 64, 66]. Differences in study popula-
tions, eligibility criteria (e.g. exclusion of drowsy patients
unable to produce speech), the interview and cognitive
testing performed, the training provided (this is variably
described in the literature), and the background and ex-
perience of the raters may all play a role in the variability
of findings [47, 58, 79]. The CAM involves binary, subjec-
tive bedside judgements of inattention, disorganised think-
ing, and level of consciousness; such judgements are more
open to variability between raters compared to objective
scoring [70, 73]. Another possible source of reduced sensi-
tivity in some studies is that the CAM algorithm generates
a negative score if disorganised thinking is not ascertained
(that is, if ‘rambling, irrelevant, or incoherent speech’ [40]
is not judged to be present) and if the level of conscious-
ness is judged to be normal, though the patient may have
inattention and other cognitive deficits and thus meet
DSM-IV or DSM-5 criteria for delirium. Similarly, if
inattention is not judged to be present but there is an
altered level of consciousness, the CAM algorithm will
generate a negative score.
This study had several strengths. Each participant was
randomised to perform either the 4AT or CAM under the
same study conditions, with the reference standard being
performed independently by a different researcher. This is
of interest given that the 4AT and the CAM are two of the
most commonly used tools internationally. Researchers
were formally trained in the use of the CAM and the
reference standard assessment. The reference assessment
involved gathering information from the DRS-R98, several
Fig. 4 Receiver operator characteristic curve for 4AT diagnostic accuracy. 4AT scores range from 0 to 12. The cut-point of > 3 is used in the
scoring scheme to denote likely delirium. The 4AT scores are considered against the reference standard delirium assessment
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tests of cognition, and also level of arousal. Neufeld and
colleagues [80] found substantial variability in delirium
reference standard assessments used in diagnostic accur-
acy studies of delirium assessment tools, with many not
using cognitive testing as part of the assessment process.
The present study had limited exclusion criteria, allowing
patients with a wide spectrum of level of severity to be
approached, including patients with a severely reduced
level of arousal. This is pertinent because reduced level of
arousal is common in emergency admissions; in one study
of clinically collected data from 35,585 consecutive, un-
selected acute medical admissions aged > 15, 7.6% of
patients had reduced level of arousal above the level of
coma, and in older populations, the prevalence is higher
[71, 81–83]. Given the close relationship of reduced
arousal with delirium [29, 32, 71, 83], it is important that
studies of delirium assessment instruments include the
full spectrum of patients with reduced arousal (excluding
coma). The study was relatively large and multicentre.
The protocol was published in advance of database lock
and analysis, and the study reporting adhered to the
STARD guidelines.
Some limitations of this study should be acknowl-
edged. In this study, only 17% of those eligible for re-
cruitment were recruited, mostly due to patients
declining to participate or no person available to provide
proxy consent. The delirium rate was 12.1% according
to the reference standard; prior studies have estimated
that the prevalence of delirium in patients aged 70 or
above at the early stages of hospital admission likely
ranges from 10 to 20% [84]. The recruitment process,
which required consenting (often from a proxy), may
have led to a sample with a moderately lower delirium
prevalence than in clinical populations. This is a known
limitation of delirium studies requiring consent [85].
Most patients with delirium lack capacity, and in the
context of the present study, this necessitated proxy
consent and an informant to score the acute change
items in the 4AT and CAM. In clinical practice, the
acute change item might be informed by staff knowledge
of the patient or not scored if no such information exists
(though an overall positive score is still possible on the
4AT because of the scoring procedure for items (A), (B),
and (C); this differs from the process that was required
in the study. With respect to the reference standard, it is
possible that objective assessments recorded and inter-
preted for this did not fully capture the researcher’s
interaction with the patient and thus the researcher’s
ascertainment of DSM-IV delirium features. Results from
the sensitivity analysis using bedside reference standard
diagnosis support this possibility, showing a higher sensi-
tivity (83%) and a similar specificity (94%) if the re-
searcher’s initial assessment was used. We aimed to
ascertain dementia status, but it is possible that some
patients had dementia but this was undiagnosed and the
IQCODE was unavailable. The number of patients with
known dementia was too low to allow an analysis of the
performance of the 4AT or CAM in patients with and
without dementia. Finally, it is possible that researcher
bias may have influenced the conduct or scoring of the
different index assessments (4AT or CAM) because the
4AT was designed in one of the sites of the study and in-
volved AMJM. However, none of the researchers collect-
ing data was involved in the development of the 4AT, the
CAM was performed by researchers trained in its use as
advised in the CAM instruction manual, and the reference
standard was administered by researchers blind to the
identity or results of the index tests.
Future studies could seek to compare the performance
of the 4AT with other delirium assessment tests, such as
the Single Question in Delirium (SQiD) [60], the Delir-
ium Triage Screen [86], the brief CAM (bCAM) [86, 87],
the 3D-CAM [88], and the Simple Query for Easy Evalu-
ation of Consciousness (SQeeC) [64]. Studies could also
evaluate the value of the individual items of the 4AT. This
is an important issue because though ideally informant his-
tory is used to make a diagnosis of delirium, in a substan-
tial proportion of patients, such history is not available at
the point of the initial assessment or even during the in-
patient stay [35, 38]. Additionally, the extent of real-world
use in large clinical datasets including rates of positive
scores should be evaluated. For example, the 4AT is man-
dated to assess for postoperative delirium in all acute hip
fracture patients in the National Health Service in England,
Wales, and Northern Ireland; in 2017, 86% of 63,471 pa-
tients were assessed with the 4AT, with 25% showing a
positive score [89]. This is possibly an underestimate of
postoperative delirium rates but suggests that the 4AT
is embedded in routine clinical practice in multiple
sites and likely detecting the majority of delirium across
these sites. Further reporting of use of the 4AT and
other tools in other large clinical datasets will be in-
formative in determining feasibility outside of research
studies.
Conclusions
The 4AT showed moderate sensitivity, high specificity,
and good overall diagnostic performance. In the present
study, the 4AT showed higher sensitivity than the CAM
and slightly lower specificity under the same study condi-
tions. The CAM has been evaluated by multiple validation
studies, and while many of these studies show high sensi-
tivity, many also show that sensitivity tends to be lower
where raters are not fully trained in the CAM or who lack
specialist training in psychiatric assessment. Taken as a
whole, the 4AT validation studies suggest that it has
comparable performance to the CAM when the CAM is
being performed by specially trained raters. In terms of its
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brevity (<2 minutes), lack of need for training, and com-
parable performance to the CAM, the 4AT can therefore
reasonably be used as an assessment tool for delirium,
particularly in clinical settings in which there is a limited
time, and in which staff involved in delirium detection
cannot undergo the substantial special training required
for use of the CAM. Additional relevant considerations
are that the 4AT can be scored if no informant history is
available at the time of assessment, and also if arousal is
impaired such that cognitive testing is not possible, which
occurs in a substantial proportion of delirium assessments
[35, 38, 64]. Given that acutely altered arousal is a highly
specific indicator of delirium [29, 30, 70, 71, 83, 90–92]
and that it often indicates a poor prognosis [81], a rapid
provisional diagnosis of delirium with appropriate investi-
gation and treatment in the absence of an external in-
formant history is reasonable. The 4AT is designed to be
able to yield a positive score in patients too unwell to
undergo an interview or cognitive testing [31, 32], and so
no patients are classed as 'unable to assess'; this facilitates
implementation and higher completion rates in clinical
practice. It is important to note, however, that as with all
short detection tools, a formal diagnosis of delirium in
clinical practice requires assessment by a suitably qualified
member of staff.
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